Robert Carter
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Caching and Content Delivery 6
- Network Traffic and Congestion Control 5
- Wireless Networks and Protocols 3
-
- MicroRNA in disease regulation 2
- Co-authors
- Mark CrovellaDavid FinkelsteinDouglas R. GreenLaura L. McCormickLewis Z. ShiChristopher P. DillonSandra MilastaPatrick Fitzgerald
- Journals
- Nature Communications (2 papers)Immunity (2 papers)Cell (2 papers)The Journal of Pathology (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Robert Carter
41 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Immunology 2.0k
- Cancer Research 630
- Computer Networks and Communications 788
- Oncology 799
- Hematology 280
Countries citing papers authored by Robert Carter
This map shows the geographic impact of Robert Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Carter more than expected).
Fields of papers citing papers by Robert Carter
This network shows the impact of papers produced by Robert Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Carter. The network helps show where Robert Carter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2019 | 34 | |
| 3 | 2018 | 17 | |
| 4 | 2018 | 242 | |
| 5 | 2018 | 55 | |
| 6 | De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation Hit paper breakdown → | 2017 | 567 |
| 7 | 2016 | 14 | |
| 8 | 2014 | 56 | |
| 9 | 2013 | 257 | |
| 10 | The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation Hit paper breakdown → | 2011 | 1614 |
| 11 | 2009 | 17 | |
| 12 | Brown's Legacy: Fulfilling the Promise of Equal Education | 2007 | 2 |
| 13 | 2006 | 1 | |
| 14 | The Conception of Brown | 2004 | 1 |
| 15 | 2004 | 105 | |
| 16 | 2004 | 1 | |
| 17 | 2000 | 6 | |
| 18 | A proinflammatory role for IL-18 in rheumatoid arthritis Hit paper breakdown → | 1999 | 537 |
| 19 | 1996 | 42 | |
| 20 | 1967 | 14 |
About Robert Carter
Robert Carter is a scholar working on Computer Networks and Communications, Cancer Research, Immunology and Allergy, Toxicology and Immunology, having authored 43 papers that have together received 4.7k indexed citations. Recurring topics across this work include Caching and Content Delivery (6 papers), Network Traffic and Congestion Control (5 papers), Wireless Networks and Protocols (3 papers), Immune Cell Function and Interaction (3 papers), T-cell and B-cell Immunology (3 papers), Sports Performance and Training (2 papers), MicroRNA in disease regulation (2 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Immunology (2.0k citations), Cancer Research (630 citations), Computer Networks and Communications (788 citations), Oncology (799 citations) and Hematology (280 citations). Robert Carter has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Mark Crovella, David Finkelstein, Douglas R. Green, Laura L. McCormick, Lewis Z. Shi, Christopher P. Dillon, Sandra Milasta, Patrick Fitzgerald, Ruoning Wang and Joshua Munger. Their work appears in journals such as Nature Communications, Immunity, Cell, The Journal of Pathology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.